Clinical Trials Directory

Trials / Completed

CompletedNCT03330470

Molecular Mediators of Physical Exercise and Carnosine Induced Effects in Patients With Preclinical and Early Stage Neurodegenerative Disease

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
26 (actual)
Sponsor
Slovak Academy of Sciences · Other Government
Sex
All
Age
55 Years – 80 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to investigate the beneficial effects of regular exercise and the impact of food supplement carnosine on cognitive, motoric and metabolic functions as well as on specific biologically active substances in volunteers with subjective (SCI) or mild (MCI) cognitive impairment, as well as in patients in early stages of Parkinson's disease. The investigators assume the immediate intervention-associated health benefit for volunteers.

Detailed description

Standard Operating Procedures for patient recruitment, data collection, data management, data analysis routinely used in Biomedical Research Center, Slovak Academy of Sciences, University Hospital Bratislava and Comenius University, Bratislava will be employed. Gait and balance parameters will be examined and analysed at the Department of Behavioural Neuroscience, Centre of Experimental Medicine, Slovak Academy of Sciences, Bratislava, Slovakia Statistical analysis will be employed to address the primary and secondary objectives, as specified in the study protocol.

Conditions

Interventions

TypeNameDescription
BEHAVIORALexerciseparticipants will be subjected to 4 months supervised exercise intervention
DIETARY_SUPPLEMENTcarnosine supplementationparticipants will be instructed to take carnosine 2 times daily
BEHAVIORALstretchingparticipants will be subjected to 4 months supervised stretching program
DIETARY_SUPPLEMENTsupplementation with placeboparticipants will be instructed to take placebo 2 times daily

Timeline

Start date
2017-01-01
Primary completion
2023-06-30
Completion
2023-09-30
First posted
2017-11-06
Last updated
2025-05-28

Locations

3 sites across 2 countries: Slovakia, Taiwan

Source: ClinicalTrials.gov record NCT03330470. Inclusion in this directory is not an endorsement.